Cue Biopharma (CUE) Asset Utilization Ratio (2018 - 2025)

Cue Biopharma has disclosed Asset Utilization Ratio across 8 years of filings, most recently posting 0.41 for Q4 2025.

• Asset Utilization Ratio for Q4 2025 came in at 0.41, up 68.66% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.41 (up 68.66% YoY), and the FY2025 annual result was 0.74, up 272.53% from the prior year.
• Asset Utilization Ratio came in at 0.41 for Q4 2025 at Cue Biopharma, up from 0.2 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.41 in Q4 2025 to a low of 0.0 in Q1 2023.
• The 5-year median for Asset Utilization Ratio is 0.13 (2022), against an average of 0.14.
• Across the five-year window, Asset Utilization Ratio slumped 96.98% in 2023 and soared 2333.89% in 2024, its largest moves.
• Cue Biopharma's Asset Utilization Ratio stood at 0.18 in 2021, then tumbled by 91.93% to 0.01 in 2022, then soared by 466.62% to 0.08 in 2023, then jumped by 186.51% to 0.24 in 2024, then jumped by 68.66% to 0.41 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.41 (Q4 2025), 0.2 (Q3 2025), and 0.26 (Q2 2025), per Business Quant data.